Back to top anchor

exciteBCI telerehabilitation: determining optimal dose and testing feasibility

Year:
2020
Duration:
24 months
Approved budget:
$245,116.70
Researchers:
Professor Denise Taylor
,
Associate Professor Nada Signal
,
Dr Imran Khan Niazi
,
Dr Sharon Olsen
,
Mrs Gemma Alder
,
Associate Professor Alain Vandal
,
Dr Usman Rashid
,
Professor Valerie Pomeroy
,
Dr Nicola Saywell
,
Dr Hugh Hanger
,
Dr Alan Davis
Health issue:
Cardiovascular/cerebrovascular
Proposal type:
Feasibility Study
Lay summary
Despite improvements in the prevention and acute management of stroke the number of strokes is projected to increase by 40% over the next ten years. Rehabilitation can reduce disability following stroke yet the availability of rehabilitation to people is limited. Research indicates that dose of rehabilitation is a key factor in reducing disability from a stroke. Yet there has been very little effort made to identify optimal dose of rehabilitation. This study builds on a carefully designed and tested brain stimulation intervention (exciteBCI), embeds it within a physiotherapy programme and delivers it remotely with psychologically sound, motivational telerehabilitation delivery methods. Before testing efficacy in a randomised controlled trial we need to know the optimal daily dose of task-specific exercise (number of repetitions) and the feasibility of using exciteBCI in people with stroke. Our aim is to determine optimal dose and investigate how well exciteBCI functions in a home setting.